Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)

Bayer

Status: Completed

Conditions: Epidemiologic Factors

Treatments: Biological: Gadobutrol (Gadovist, BAY86-4875)

Study type: Observational

Funder types: Industry

Identifiers

NCT00874640

14317

GV0810DE (Other Identifier)

Details and patient eligibility

About

To evaluate patient characteristics in the current daily radiological practice of Gadovist application. Special focus will be laid on the individual risk factors of patients, the indications for and the dose of Gadovist application.

Secondary objective is to prove the known safety profile (especially rare adverse events) of Gadovist and to collect data on handling problems with different application forms (one questionnaire per center).

Enrollment: 3,711 patients

Sex: All

Ages: 7+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with indication for a MRT or MR-Angiography and for whom the radiologist has decided to use the contrast medium Gadovist

Exclusion criteria

• No exclusion criteria besides the contraindications for the use of Gadovist as mentioned in the German product information.

Trial design

3,711 participants in 1 patient group

Group 1

Treatment:

Biological: Gadobutrol (Gadovist, BAY86-4875)